CI The Cigna Group Common Stock
O The Cigna Group Common Stock Przegląd firmy z Wikipedii
The Cigna Group is an American multinational for-profit managed healthcare and insurance company based in Bloomfield, Connecticut. Cigna's insurance subsidiaries are major providers of medical, dental, disability, life and accident insurance and related products and services, the majority of which are offered through employers and other groups.
Czytaj więcej
The Cigna Group is an American multinational for-profit managed healthcare and insurance company based in Bloomfield, Connecticut. Cigna's insurance subsidiaries are major providers of medical, dental, disability, life and accident insurance and related products and services, the majority of which are offered through employers and other groups (e.g., governmental and non-governmental organizations, unions and associations).
Cigna is incorporated in Delaware. The company ranked No. 15 in the 2023 Fortune 500 list of the largest U.S. corporations by total revenue, and the company took 68th place in the 2023 Forbes Global 2000 ranking. It has been embroiled in controversies, including engaging in automatic denials of insurance claims without reviewing them.
History
Cigna was formed by the 1982 merger of the Connecticut General Life Insurance Company (CG) and INA Corporation (the parent corporation of Insurance Company of North America, the first stock insurance company in America). The company name, Cigna, is a mix of letters from the merging companies, CG and INA. Insurance Company of North America was formed in 1792, while CG was created in 1865 by a special act of the Governor of Connecticut. In October 1871, the great Chicago Fire burned for two days, destroyed 2,000 acres, and left 100,000 people in Illinois homeless. INA paid $650,000, one of only 51 insurance companies (out of a total of 202) to pay claims in full.
Cigna sold the majority of its life insurance operations to Lincoln National Corporation in 1997.
In October 2011, Cigna agreed to buy HealthSpring Inc. for $3.8 billion to jump-start its business selling Medicare plans from 46,000 Medicare Advantage members to almost 400,000 Medicare Advantage members. The payment would come from an issue of new equity to cover about 20 percent of the value, with the rest funded by additional cash and debt. In 2013, Cigna operated in 30 countries, had approximately 35,800 employees and managed around US$53.734 billion in assets.
In June 2015, U.S. health insurer Anthem Inc. announced that it would acquire Cigna for $47 billion in cash and stock. Anthem confirmed it had reached a deal to buy Cigna on July 24, 2015. On July 21, 2016, the US Justice Department filed an antitrust suit to block the proposed merger, and a District Court ruling on February 8, 2017, blocked the merger on anticompetitive grounds. That month, Cigna Corp. called off its $48 billion merger agreement with Anthem Inc., with Anthem stating it would "continue to enforce its rights under the merger agreement and remains committed to closing the transaction." After exhausting federal appeals of the antitrust merger block, the companies turned on each other in Delaware's Court of Chancery. The legal saga came to an end with an August 31, 2020 decision denying both companies claims for compensation from the other for the failed merger.
On March 7, 2018, it was announced that Cigna would acquire Express Scripts in a $67 billion deal and on August 24, 2018, the shareholders of Cigna and Express Scripts approved the deal.
In June 2020, Cigna formed a strategic alliance with Priority Health to make comprehensive health care coverage more affordable and accessible to Michigan employers and customers.
In September 2020, Cigna rebranded its health services portfolio under the name Evernorth, which included Express Scripts, Accredo, and eviCore.
In October 2020, it was announced that Cigna and Envision Healthcare had renewed their agreement to include Envision's clinicians as in-network providers for Cigna's members. In 2021, Molina Healthcare acquired Cigna's Medicaid contracts in Texas for US$60 million.
On February 13, 2023, Cigna renamed its holding company The Cigna Group, its health benefits provider business unit Cigna Healthcare, and its Evernorth business unit Evernorth Health Services.
In January 2024, the company agreed with the Health Care Service Corporation (HCSC) to sell Cigna Group's Medicare Advantage, Cigna Supplemental Benefits, Medicare Part D, and CareAllies businesses. The total value of the transaction is about $3.7 billion. The deal also included a four-year service agreement under which Evernorth Health Services, a subsidiary of the Cigna Group, will continue to provide pharmacy benefits to Medicare beneficiaries. The deal closed on March 19, 2025.
On 8 July 2025, HCSC announced that its newly acquired Cigna Medicare Advantage products will be renamed Healthspring, which was a dormant brand name acquired as part of HCSC deal with the Cigna Group. A logo and website for the newly revived Healthspring brand have already been launched by HCSC, which now owns Healthspring.
Cigna Global Health Benefits
Cigna Global Health Benefits is a business unit within Cigna. The company is headquartered in Wilmington, Delaware, close to Philadelphia. Additional Cigna Global Health Benefits operations are located in Visalia, California, and Greenock, Scotland and Shanghai, China and Antwerp, Belgium. Sales offices are located in North America, Europe, Asia and the Middle East.
Products and services
CGHB global health plans typically include medical, dental, behavioral, and disability coverage, as well as business travel and life insurance components. Expatriates are defined as employees of multinational companies who work outside their home country on short- or long-term international assignments. CGHB maintains its own, in-house international claims platform, and offers a network of physicians and hospitals for its members (including 550,000 in the U.S. and more than 141,000 outside the U.S.).
Public relations and lobbying
Cigna spent more than $4.4 million from 2005 to 2009 on lobbying to attain legislation that the company favors. This includes $720,000 spent in 2009 alone, when it had 20 lobbyists at five firms working on its behalf.
In 2008, the head of Cigna's public relations, Wendell Potter, resigned, becoming a whistleblower who gave testimony in 2009 to the U.S. Senate Committee on Commerce, Science and Transportation in favor of reform of the health care industry.
Controversies
Automatically rejecting claims with no review
In 2023, Cigna was criticized for allowing company doctors to reject claims even if they had not opened the patient's file. The company was found to be using a system, "PXDX," that, according to ProPublica, "saved money in two ways. It allowed Cigna to begin turning down claims that it had once paid. And it made it cheaper to turn down claims, because the company's doctors never had to open a file or conduct any in-depth review. They simply denied the claims in bulk with an electronic signature." The speed with which denials were placed was termed internally as "click and close."
Nataline Sarkisyan liver transplant case
In December 2007, Cigna refused to pay for a liver transplant of a California teenage girl, Nataline Sarkisyan, coming under scrutiny as a result. There was a liver ready and waiting to be transplanted, and doctors estimated she had a 65% chance of surviving at least six months. In response to much protest and public scrutiny, Cigna reversed its decision, though Ms. Sarkisyan died awaiting the transplant.
Even though liver transplants have been performed since 1963 and are a well-accepted treatment option for end-stage liver disease and acute liver failure, Cigna defended its actions by claiming that there was insufficient data to show that a transplant for a patient in Sarkisyan's condition would be safe and effective. The California court agreed with Cigna's position that the Sarkisyans’ claims regarding Cigna's decision-making were preempted by federal ERISA law. On April 16, 2009, the United States District Court for the Central District of California dismissed all of the claims against Cigna related to the coverage determination.
The UK newspaper The Guardian in their Esc and Ctrl videoblog about control of the Internet by corporations, documented the incident with Nataline Sarkisyan and the former vice president of Cigna talking about astroturfing, the practice of creating fake blogs by interested groups, e.g. health insurance companies, to push claims that are profitable for said company into media, e.g. dismissing universal health care.
Other controversies
In 2002, Cigna was alleged in violation of the Securities Exchange Act for earnings manipulation. Its common stock price plummeted significantly as a result.
In 2015, the American Consumer Satisfaction Index named Cigna as one of the most hated companies in the U.S. Cigna's name returned on the ACSI's most hated list in 2018.
In August 2020, the Department of Justice filed a lawsuit against Cigna alleging that the company defrauded Medicare Advantage, Medicare, and Medicaid for $1.4B by submitting diagnostic codes for health conditions that patients did not have.
In November 2020, investors sued Cigna's CEO and board, alleging that they had used "black-ops-style" tactics to "blow up" the potential merger with Anthem in 2017. One pension fund accused Cigna CEO David Cordani of seeking to poison the deal after he had failed to secure the top post in the resulting company. The fund claimed he had utilized lawyers and public relations specialists to set up a "Trojan Horse" campaign. The merger would have produced the largest U.S. health insurer in 2017.
Evaluations
Cigna received gold in the 2009 Gartner & 1to1 Customer Experience Excellence Award. The awards are given to the companies that "most clearly demonstrate exemplary customer relationship strategy and an unrivaled level of excellence in delivering the customer experience".
In January 2010, Cigna received the JD Power award for customer service for all of its call centers for the fourth time in a row.
In 2011, the California Nurses Association determined that Cigna denied roughly 39.6% of all claims (compared to competitors such as Aetna, who denied about 5.9% of all claims in the same time frame).
Strategic alliances
On April 16, 2010, Cigna announced an alliance with Humana group to offer a streamlined Medicare Advantage offering through employer clients for retirees. In November 2023, Reuters reported that Cigna and Humana were in talk to merge, in a deal totalling $60 billion. In December 2023, The Wall Street Journal reported that merger talks ended.
In November 2011, Cigna and TTK Group, an Indian business conglomerate focused on healthcare, formed a joint venture called Cigna TTK to develop a health insurance business in India, subject to obtaining government approvals.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
CI Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
CI Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR
| Data ex-dywidendy | Kwota |
|---|---|
| 4 czerwca 2026 | $1,5600 |
| 5 marca 2026 | $1,5600 |
| 4 grudnia 2025 | $1,5100 |
| 4 września 2025 | $1,5100 |
| 3 czerwca 2025 | $1,5100 |
| 5 marca 2025 | $1,5100 |
| 4 grudnia 2024 | $1,4000 |
| 4 września 2024 | $1,4000 |
| 4 czerwca 2024 | $1,4000 |
| 5 marca 2024 | $1,4000 |
| 5 grudnia 2023 | $1,2300 |
| 5 września 2023 | $1,2300 |
| 6 czerwca 2023 | $1,2300 |
| 7 marca 2023 | $1,2300 |
| 5 grudnia 2022 | $1,1200 |
| 6 września 2022 | $1,1200 |
| 7 czerwca 2022 | $1,1200 |
| 8 marca 2022 | $1,1200 |
| 6 grudnia 2021 | $1,0000 |
| 7 września 2021 | $1,0000 |
CI Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
- Mocne kupno 11 32,4%
- Kup 16 47,1%
- Trzymaj 7 20,6%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
24 analityków · 2026-08-21Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $7.78 | $7.83 | -0.05% |
| 31 marca 2026 | $7.79 | $7.84 | -0.05% |
| 31 grudnia 2025 | $8.08 | $8.11 | -0.03% |
| 30 września 2025 | $7.83 | $7.88 | -0.05% |
| 30 czerwca 2025 | $7.20 | $7.37 | -0.17% |
| 31 marca 2025 | $6.74 | $6.54 | 0.20% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| CI | $72.51B | 12.4 | 11.2% | 2.2% | 14.4% | — |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | — |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| DGX | $19.09B | 19.8 | 11.8% | 9.0% | 14.2% | — |
| GH | $13.34B | -30.8 | 32.9% | -42.4% | 205.7% | — |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| BTSG | $7.20B | 43.0 | 28.2% | 1.5% | 10.8% | 11.8% |
| DVA | $7.79B | 11.5 | 6.5% | 5.5% | -281.8% | — |
| HIMS | — | 63.7 | 59.0% | 5.5% | 23.3% | 73.8% |
| HNGE | $0 | -6.0 | 50.6% | -89.9% | -299.8% | 79.7% |
| CHE | — | 23.3 | 4.1% | 10.5% | 24.4% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 12
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $274.90B | $247.12B | $195.26B | $180.52B | $174.07B | $160.40B | $153.57B | $48.65B | $41.81B | $39.84B | |
| Cost of Revenue | $214.99B | $182.51B | $133.80B | $124.83B | $117.55B | $103.48B | $97.67B | $4.79B | $2.46B | $2.47B | |
| SG&A Expense | $14.62B | $14.84B | $14.82B | $13.17B | $13.01B | $14.07B | $14.05B | $11.93B | $10.03B | $9.79B | |
| Operating Income | $9.20B | $9.42B | $8.54B | $8.45B | $7.94B | $8.15B | $8.08B | $4.16B | $3.94B | $3.09B | |
| Other Non-op | $-1.41B | $-1.44B | $-1.45B | $-1.23B | $-1.21B | $-1.44B | $-1.68B | $-498M | $-252M | $-278M | |
| Pretax Income | $7.78B | $5.27B | $5.51B | $8.40B | $6.79B | $10.87B | $6.57B | $3.58B | $3.61B | $2.98B | |
| Income Tax | $1.49B | $1.49B | $141M | $1.61B | $1.37B | $2.38B | $1.45B | $935M | $1.37B | $1.14B | |
| Net Income | $5.96B | $3.43B | $5.16B | $6.78B | $5.42B | $8.49B | $5.12B | $2.65B | $2.23B | $1.84B | |
| EPS (Basic) | $22.33 | $12.25 | $17.57 | $21.66 | $15.89 | $23.17 | $13.58 | $10.69 | $8.92 | $7.31 | |
| EPS (Diluted) | $22.18 | $12.12 | $17.39 | $21.41 | $15.75 | $22.96 | $13.44 | $10.54 | $8.77 | $7.19 | |
| Shares (Diluted) | 268,563,000 | 283,218,000 | 296,882,000 | 313,065,000 | 340,966,000 | 368,389,000 | 379,817,000 | 250,225,000 | 255,072,000 | 259,647,000 | |
| EBITDA | $11.97B | $12.19B | $11.57B | $11.35B | $10.86B | $10.96B | $11.73B | $4.86B | · | · |
Bilans 29
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7.68B | $7.55B | $7.82B | $5.92B | $5.08B | $10.18B | $4.62B | $3.85B | $2.97B | $3.19B | |
| Short-term Investments | $1.06B | $665M | $925M | $905M | $920M | $1.33B | $937M | $2.04B | $2.14B | · | |
| Receivables | $28.77B | $24.23B | $17.72B | $17.22B | $15.07B | $12.19B | $10.72B | $10.47B | $3.15B | · | |
| Inventory | $7.34B | $6.69B | $5.64B | $4.78B | $3.72B | $3.17B | $2.66B | $2.82B | $228M | · | |
| Other Current Assets | $2.98B | $2.73B | $2.17B | $1.30B | $1.28B | $930M | $1.40B | $1.24B | $820M | · | |
| Current Assets | $47.81B | $48.87B | $37.35B | $30.12B | $36.13B | $27.80B | $29.84B | $20.43B | $9.31B | · | |
| PP&E (Net) | $3.65B | · | · | $3.77B | $3.69B | $4.21B | $4.42B | $4.56B | $1.56B | · | |
| PP&E (Gross) | $13.75B | · | · | $11.20B | $10.28B | $9.78B | $8.92B | $7.96B | $4.61B | · | |
| Accum. Depreciation | $10.10B | · | · | $7.43B | $6.59B | $5.58B | $4.50B | $3.40B | $3.05B | · | |
| Goodwill | $44.92B | $44.37B | $44.26B | $45.81B | $45.81B | $44.65B | $44.60B | $44.51B | $6.16B | $5.98B | |
| Intangibles | $28.56B | $29.42B | $30.86B | $32.49B | $34.10B | $35.18B | $36.56B | $39.00B | $345M | · | |
| Other Non-current Assets | $2.88B | $2.79B | $3.42B | $2.70B | $3.40B | $2.69B | $2.28B | $1.63B | $1.43B | · | |
| Total Assets | $157.92B | $155.88B | $152.76B | $143.88B | $154.89B | $155.45B | $155.77B | $153.23B | $61.76B | · | |
| Accounts Payable | $10.66B | $9.29B | $8.55B | $7.78B | $6.66B | $5.48B | $5.09B | $4.37B | $184M | · | |
| Short-term Debt | $0 | $880M | $1.24B | $0 | $2.03B | $1.03B | $944M | $1.50B | $100M | · | |
| Current Liabilities | $56.34B | $57.98B | $48.72B | $41.23B | $43.57B | $36.02B | $40.14B | $31.89B | $11.01B | · | |
| Capital Leases | · | · | $340M | $346M | · | $491M | $465M | · | · | · | |
| Deferred Tax | $7.14B | $6.97B | $7.17B | $7.79B | $8.35B | $8.94B | $9.39B | $9.45B | $0 | · | |
| Other Non-current Liabilities | $4.24B | $3.21B | $3.44B | $2.77B | $3.76B | $4.63B | $4.46B | $3.47B | $2.84B | · | |
| Total Liabilities | $116.05B | $114.64B | $106.41B | $99.13B | $107.70B | $105.06B | $110.39B | $112.15B | $48.00B | · | |
| Long-term Debt | · | · | · | · | · | · | · | $39.52B | · | · | |
| Total Debt | $0 | $880M | $1.24B | $0 | $2.03B | $1.03B | $944M | $1.50B | · | · | |
| Common Stock | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $74M | · | |
| Retained Earnings | $47.87B | $43.52B | $41.65B | $37.94B | $32.59B | $28.57B | $20.16B | $15.09B | $15.80B | · | |
| Treasury Stock | $35.14B | $31.44B | $24.24B | $21.84B | $14.18B | $6.37B | $2.19B | $104M | $4.02B | · | |
| AOCI | $-2.81B | $-2.34B | $-1.86B | $-1.66B | $-884M | $-861M | $-941M | $-1.71B | $-1.08B | · | |
| Stockholders' Equity | $41.71B | $41.03B | $46.22B | $44.67B | $47.11B | $50.32B | $45.34B | $41.03B | $13.71B | · | |
| Liabilities + Equity | $157.92B | $155.88B | $152.76B | $143.88B | $154.89B | $155.45B | $155.77B | $153.23B | $61.76B | · | |
| Shares Outstanding | 263,464,000 | 273,789,000 | 292,504,000 | 298,676,000 | 322,948,000 | 354,771,000 | 372,531,000 | 380,924,000 | 0 | 0 |
Przepływy pieniężne 18
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2.77B | $2.77B | $3.04B | $2.94B | $2.92B | $2.80B | $3.65B | $695M | $566M | $610M | |
| Deferred Tax | $326M | $-95M | $-1.66B | $-472M | $-216M | $-386M | $-313M | $-101M | $242M | $74M | |
| Amort. of Intangibles | $1.74B | $1.70B | $1.82B | $1.88B | $2.00B | $1.98B | $2.95B | $235M | $115M | $151M | |
| Restructuring | · | $0 | $252M | $22M | $168M | · | · | · | · | · | |
| Other Non-cash | $543M | $3.90B | $5.07B | $-547M | $-927M | $-555M | $1.03B | $530M | · | · | |
| Operating Cash Flow | $9.60B | $10.36B | $11.81B | $8.66B | $7.19B | $10.35B | $9.48B | $3.77B | $4.09B | $4.03B | |
| CapEx | · | · | · | · | · | · | $1.05B | $528M | $471M | $461M | |
| Investing Cash Flow | $-4.41B | $-2.10B | $-5.17B | $3.10B | $-3.61B | $2.98B | $-734M | $-26.38B | $-1.70B | $-2.57B | |
| Debt Issued | $4.46B | $4.46B | $1.49B | $0 | $4.26B | $3.46B | $0 | $22.86B | $1.58B | $0 | |
| Net Debt Issued | $261M | $1.46B | $-1.48B | $-500M | $-318M | $-4.58B | $-4.49B | $22.73B | · | · | |
| Stock Issued | $203M | $305M | $187M | $389M | $326M | $376M | $224M | $68M | $131M | $36M | |
| Stock Repurchased | $3.62B | $7.03B | $2.28B | $7.61B | $7.74B | $4.04B | $1.99B | $342M | $2.73B | $139M | |
| Net Stock Activity | $-3.42B | $-6.73B | $-2.10B | $-7.22B | $-7.42B | $-3.67B | $-1.76B | $-274M | · | · | |
| Dividends Paid | $1.61B | $1.57B | $1.45B | $1.38B | $1.34B | $15M | $15M | · | · | · | |
| Financing Cash Flow | $-6.42B | $-7.65B | $-4.29B | $-11.24B | $-8.21B | $-8.53B | $-7.19B | $23.52B | $-2.65B | $-225M | |
| Net Change in Cash | $-1.20B | $594M | $2.36B | $428M | $-4.70B | $4.83B | $1.56B | $883M | $-213M | $1.22B | |
| Taxes Paid | $399M | $898M | $1.47B | $1.85B | $2.24B | $1.84B | $1.78B | $1.02B | $1.04B | $1.06B | |
| Free Cash Flow | · | · | · | · | · | · | $8.44B | $3.24B | · | · |
Rentowność 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.4% | 3.8% | 4.4% | 4.7% | 4.6% | 5.1% | 5.3% | 8.6% | · | · | |
| Net Margin | 2.2% | 1.5% | 2.8% | 3.7% | 3.1% | 5.3% | 3.3% | 5.4% | · | · | |
| Pretax Margin | 2.8% | 2.1% | 2.8% | 4.6% | 3.9% | 6.8% | 4.3% | 7.4% | · | · | |
| EBITDA Margin | 4.4% | 4.9% | 5.9% | 6.3% | 6.2% | 6.8% | 7.6% | 10.0% | · | · | |
| ROA | 3.8% | 2.5% | 3.6% | 4.5% | 3.5% | 5.5% | 3.3% | 2.5% | · | · | |
| ROE | 14.4% | 8.7% | 11.8% | 14.7% | 11.1% | 17.8% | 11.9% | 9.7% | · | · | |
| ROIC | 17.8% | 16.1% | 17.5% | 15.1% | 12.9% | 12.4% | 13.6% | 7.2% | · | · |
Płynność i wypłacalność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.8 | 0.8 | 0.7 | 0.8 | 0.8 | 0.7 | 0.6 | · | · | |
| Quick Ratio | 0.7 | 0.6 | 0.5 | 0.6 | 0.5 | 0.7 | 0.4 | 0.5 | · | · | |
| Debt / Equity | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | · |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.8 | 1.6 | 1.3 | 1.2 | 1.1 | 1.0 | 1.0 | 0.5 | · | · | |
| Inventory Turnover | 30.6 | 29.6 | 25.7 | 29.4 | 34.1 | 35.5 | 35.6 | 3.1 | · | · | |
| Receivables Turnover | 10.4 | 11.8 | 11.2 | 11.2 | 12.8 | 14.0 | 14.5 | 7.1 | · | · |
Stopy Wzrostu 10
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.2% | 26.6% | 8.2% | 3.7% | 8.5% | · | · | · | · | · | |
| Revenue CAGR 3Y | 15.0% | 12.4% | 6.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.4% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 83.0% | -30.3% | -18.8% | 35.9% | -31.4% | · | · | · | · | · | |
| EPS CAGR 3Y | 1.2% | -8.4% | -8.8% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -0.69% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 73.5% | -33.5% | -23.9% | 25.1% | -36.1% | · | · | · | · | · | |
| Net Income CAGR 3Y | -4.2% | -14.1% | -15.3% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -6.8% | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 154.8% | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 16
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $274.90B | $247.12B | $195.26B | $180.52B | $174.07B | $160.40B | $153.57B | $48.65B | · | · | |
| Net Income TTM | $5.96B | $3.43B | $5.16B | $6.78B | $5.42B | $8.49B | $5.12B | $2.65B | · | · | |
| Market Cap | $72.51B | $75.60B | $87.59B | $98.96B | $74.16B | $73.86B | $76.18B | $72.35B | · | · | |
| Enterprise Value | $63.78B | $68.27B | $80.08B | $92.13B | $70.18B | $63.37B | $71.57B | $67.95B | · | · | |
| P/E | 12.4 | 22.8 | 17.2 | 15.5 | 14.6 | 9.1 | 15.2 | 18.0 | · | · | |
| P/S | 0.3 | 0.3 | 0.4 | 0.5 | 0.4 | 0.5 | 0.5 | 1.5 | · | · | |
| P/B | 1.7 | 1.8 | 1.9 | 2.2 | 1.6 | 1.5 | 1.7 | 1.8 | · | · | |
| P / Cash Flow | 7.6 | 7.3 | 7.4 | 11.4 | 10.3 | 7.1 | 8.0 | 19.2 | · | · | |
| P / FCF | · | · | · | · | · | · | 9.0 | 22.3 | · | · | |
| EV / EBITDA | 5.3 | 5.6 | 6.9 | 8.1 | 6.5 | 5.8 | 6.1 | 14.0 | · | · | |
| EV / FCF | · | · | · | · | · | · | 8.5 | 21.0 | · | · | |
| EV / Revenue | 0.2 | 0.3 | 0.4 | 0.5 | 0.4 | 0.4 | 0.5 | 1.4 | · | · | |
| Dividend Yield | 2.2% | 2.1% | 1.7% | 1.4% | 1.8% | 0.02% | 0.02% | · | · | · | |
| Earnings Yield | 8.1% | 4.4% | 5.8% | 6.5% | 6.9% | 11.0% | 6.6% | 5.5% | · | · | |
| Payout Ratio | 27.0% | 41.5% | 27.0% | 20.5% | 24.8% | · | · | · | · | · | |
| Annual Payout | $1.61B | $1.57B | $1.45B | $1.38B | $1.34B | $15M | $15M | · | · | · |
Rachunek zysków i strat 12
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $71.67B | $68.49B | $72.47B | $69.75B | $67.18B | $65.50B | $65.65B | $63.69B | $60.52B | $57.26B | $51.11B | $49.05B | $48.59B | $46.52B | $45.75B | $45.28B | |
| Cost of Revenue | $56.70B | $54.10B | $57.80B | $55.53B | $53.27B | $48.40B | $49.02B | $47.56B | $44.49B | $41.43B | $35.26B | $33.64B | $33.44B | $31.46B | $32.09B | $31.78B | |
| SG&A Expense | $3.47B | $3.72B | $3.61B | $3.36B | $3.43B | $4.21B | $3.87B | $3.59B | $3.68B | $3.71B | $4.06B | $3.79B | $3.43B | $3.54B | $3.48B | $3.15B | |
| Operating Income | $2.68B | $2.36B | $2.35B | $2.58B | $2.31B | $1.97B | $2.17B | $2.58B | $2.41B | $2.26B | $2.06B | $2.24B | $2.22B | $2.02B | $1.75B | $2.14B | |
| Other Non-op | $-356M | $-357M | $-362M | $-347M | $-337M | $-362M | $-362M | $-376M | $-375M | $-322M | $-360M | $-365M | $-363M | $-358M | $-324M | $-304M | |
| Pretax Income | $2.26B | $2.27B | $1.82B | $2.29B | $2.02B | $1.65B | $2.01B | $1.19B | $1.99B | $79M | $188M | $1.84B | $1.88B | $1.60B | $1.36B | $3.49B | |
| Income Tax | $382M | $409M | $543M | $322M | $389M | $239M | $473M | $367M | $360M | $291M | $-919M | $391M | $374M | $295M | $136M | $713M | |
| Net Income | $1.66B | $1.65B | $943M | $1.97B | $1.53B | $1.32B | $1.19B | $825M | $1.63B | $-212M | $899M | $1.45B | $1.51B | $1.31B | $1.22B | $2.78B | |
| EPS (Basic) | $6.31 | $6.30 | $4.67 | $7.02 | $5.76 | $4.88 | $5.06 | $2.65 | $5.51 | $-0.97 | $3.54 | $4.79 | $4.96 | $4.28 | $3.89 | $9.07 | |
| EPS (Diluted) | $6.29 | $6.26 | $4.64 | $6.98 | $5.71 | $4.85 | $5.01 | $2.63 | $5.45 | $-0.97 | $3.49 | $4.74 | $4.92 | $4.24 | $3.82 | $8.97 | |
| Shares (Diluted) | 263,962,000 | 264,017,000 | -540,074,000 | 267,530,000 | 268,154,000 | 272,953,000 | -568,695,000 | 281,396,000 | 284,052,000 | 286,465,000 | -596,127,000 | 297,131,000 | 296,879,000 | 298,999,000 | -634,038,000 | 307,517,000 | |
| EBITDA | $3.33B | $3.01B | · | $3.27B | $2.99B | $2.65B | · | $2.58B | $2.41B | $3.00B | · | $2.24B | $2.22B | $2.76B | · | $2.14B |
Bilans 28
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6.30B | $7.04B | $7.68B | $6.03B | $4.33B | $8.33B | $7.55B | $5.89B | $6.79B | $8.44B | · | $8.50B | $9.59B | $7.93B | · | $7.08B | |
| Short-term Investments | $959M | $812M | $1.06B | $883M | $813M | $727M | $665M | $864M | $1.07B | $1.11B | · | $1.05B | $872M | $914M | · | $783M | |
| Receivables | $30.80B | $26.61B | $28.77B | $31.71B | $31.15B | $26.93B | $24.23B | $27.85B | $25.11B | $20.56B | · | $19.08B | $18.33B | $17.70B | · | $17.27B | |
| Inventory | $5.85B | $5.83B | $7.34B | $5.63B | $5.97B | $5.18B | $6.69B | $5.08B | $5.17B | $4.63B | · | $4.42B | $4.51B | $4.21B | · | $4.02B | |
| Other Current Assets | $3.09B | $2.74B | $2.98B | $2.49B | $2.47B | $2.39B | $2.73B | $2.67B | $2.66B | $2.26B | · | $1.48B | $1.41B | $1.26B | · | $1.02B | |
| Current Assets | $46.99B | $43.03B | $47.81B | $46.73B | $44.72B | $43.55B | $48.87B | $49.22B | $46.22B | $43.36B | · | $34.52B | $34.71B | $32.03B | · | $30.17B | |
| PP&E (Net) | · | · | $3.65B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| PP&E (Gross) | · | · | $13.75B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $10.10B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Goodwill | $45.53B | $45.53B | $44.92B | $44.92B | $44.38B | $44.37B | $44.37B | $44.37B | $44.26B | $44.26B | $44.26B | $45.81B | $45.81B | $45.81B | $45.81B | $45.81B | |
| Intangibles | $26.93B | $27.32B | $28.56B | $28.98B | $28.67B | $29.05B | $29.42B | $29.79B | $30.18B | $30.49B | · | $31.32B | $31.71B | $32.10B | · | $32.88B | |
| Other Non-current Assets | $3.32B | $3.25B | $2.88B | $3.39B | $2.93B | $3.00B | $2.79B | $3.18B | $3.28B | $3.29B | · | $3.15B | $2.50B | $2.56B | · | $2.48B | |
| Total Assets | $157.08B | $153.27B | $157.92B | $157.92B | $151.65B | $150.66B | $155.88B | $157.64B | $155.45B | $153.12B | · | $149.65B | $150.05B | $147.98B | · | $144.21B | |
| Accounts Payable | $10.41B | $9.88B | $10.66B | $9.35B | $9.94B | $9.14B | $9.29B | $8.52B | $9.28B | $8.12B | · | $7.67B | $8.07B | $7.36B | · | $6.87B | |
| Short-term Debt | $1.00B | · | $0 | · | · | $0 | $880M | $1.64B | $790M | $884M | · | $1.51B | $200M | · | · | $0 | |
| Current Liabilities | $55.56B | $52.61B | $56.34B | $56.45B | $56.78B | $55.74B | $57.98B | $57.06B | $55.37B | $51.98B | · | $47.06B | $47.34B | $44.73B | · | $41.12B | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $368M | |
| Deferred Tax | $6.73B | $6.85B | $7.14B | $7.00B | $6.78B | $6.88B | $6.97B | $6.79B | $6.95B | $7.03B | · | $7.48B | $7.59B | $7.71B | · | $7.78B | |
| Other Non-current Liabilities | $5.61B | $4.77B | $4.24B | $3.87B | $3.65B | $3.58B | $3.21B | $3.03B | $3.54B | $3.65B | · | $2.93B | $2.58B | $2.69B | · | $3.18B | |
| Total Liabilities | $114.17B | $110.82B | $116.05B | $115.91B | $111.22B | $110.24B | $114.64B | $115.34B | $113.92B | $111.77B | · | $103.88B | $104.53B | $103.38B | · | $99.08B | |
| Total Debt | $1.00B | · | · | · | · | $0 | · | $1.64B | $790M | $884M | · | $1.51B | $200M | · | · | $0 | |
| Common Stock | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | · | $4M | $4M | $4M | · | $4M | |
| Retained Earnings | $50.35B | $49.11B | $47.87B | $47.03B | $45.56B | $44.43B | $43.52B | $42.48B | $42.13B | $40.98B | · | $40.98B | $39.94B | $38.84B | · | $37.04B | |
| Treasury Stock | $35.47B | $35.22B | $35.14B | $34.13B | $34.13B | $33.06B | $31.44B | $29.41B | $29.41B | $27.77B | · | $23.74B | $23.05B | $22.91B | · | $19.39B | |
| AOCI | $-4.36B | $-3.60B | $-2.81B | $-2.80B | $-2.82B | $-2.59B | $-2.34B | $-2.16B | $-2.44B | $-2.32B | · | $-2.12B | $-1.88B | $-1.77B | · | $-2.01B | |
| Stockholders' Equity | $42.62B | $42.21B | $41.71B | $41.80B | $40.21B | $40.23B | $41.03B | $42.09B | $41.33B | $41.18B | · | $45.69B | $45.45B | $44.50B | · | $45.04B | |
| Liabilities + Equity | $157.08B | $153.27B | $157.92B | $157.92B | $151.65B | $150.66B | $155.88B | $157.64B | $155.45B | $153.12B | · | $149.65B | $150.05B | $147.98B | · | $144.21B | |
| Shares Outstanding | · | · | 263,464,000 | · | · | · | 273,789,000 | · | · | · | 292,504,000 | · | · | · | 298,676,000 | · |
Przepływy pieniężne 15
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $655M | $650M | $722M | $697M | $682M | $674M | $646M | $650M | $738M | $741M | $765M | $766M | $755M | $749M | $735M | $726M | |
| Amort. of Intangibles | $389M | $390M | $463M | $436M | $422M | $422M | $424M | $436M | $420M | $423M | $451M | $454M | $455M | $459M | $457M | $460M | |
| Restructuring | · | · | · | $222M | $129M | $215M | · | $0 | $0 | $0 | $252M | $0 | $0 | · | $0 | $0 | |
| Other Non-cash | · | $-1.17B | · | · | · | $-163M | · | · | · | $4.31B | · | · | · | $2.97B | · | · | |
| Operating Cash Flow | $-421M | $1.13B | $6.15B | $3.42B | $-1.89B | $1.92B | $5.21B | $46M | $265M | $4.84B | $1.47B | $2.83B | $2.49B | $5.03B | $2.10B | $3.28B | |
| Investing Cash Flow | $-503M | $-637M | $-420M | $-4.39B | $-797M | $1.20B | $-191M | $-776M | $-640M | $-495M | $-440M | $-1.34B | $-414M | $-2.98B | $-616M | $4.45B | |
| Debt Issued | · | · | $-3M | $4.46B | $0 | $0 | $0 | $0 | $0 | $4.46B | $0 | $0 | $0 | $1.49B | $0 | $0 | |
| Net Debt Issued | · | $-550M | · | · | · | $-700M | · | · | · | $2.25B | · | · | · | $1.41B | · | · | |
| Stock Issued | $101M | $57M | $25M | $37M | $72M | $69M | $22M | $62M | $40M | $181M | $74M | $54M | $29M | $30M | $72M | $100M | |
| Stock Repurchased | $280M | $0 | $1.00B | $0 | $1.11B | $1.51B | $2.02B | $0 | $990M | $4.02B | $544M | $624M | $154M | $962M | $1.73B | $3.50B | |
| Net Stock Activity | · | $57M | · | · | · | $-1.44B | · | · | · | $-3.84B | · | · | · | $-932M | · | · | |
| Dividends Paid | $409M | $417M | $396M | $402M | $401M | $412M | $384M | $390M | $392M | $401M | $358M | $362M | $362M | $368M | $334M | $341M | |
| Financing Cash Flow | $207M | $-1.14B | $-4.07B | $2.66B | $-1.33B | $-3.68B | $-3.25B | $439M | $-2.31B | $-2.53B | $-1.25B | $-2.57B | $-435M | $-37M | $-2.64B | $-5.52B | |
| Net Change in Cash | $-724M | $-656M | $1.67B | $1.69B | $-3.99B | $-555M | $1.75B | $-273M | $-2.69B | $1.81B | $-209M | $-1.09B | $1.65B | $2.01B | $-1.14B | $2.19B | |
| Taxes Paid | · | · | $43M | $6M | $210M | $140M | $59M | $272M | $457M | $110M | $91M | $454M | $849M | $77M | $504M | $435M |
Rentowność 7
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.7% | 3.4% | · | 3.7% | 3.4% | 3.0% | · | 4.0% | 4.0% | 3.9% | · | 4.6% | 4.6% | 4.3% | · | 4.7% | |
| Net Margin | 2.3% | 2.4% | · | 2.8% | 2.4% | 2.1% | · | 1.3% | 2.7% | -0.37% | · | 2.9% | 3.1% | 2.8% | · | 6.1% | |
| Pretax Margin | 3.1% | 3.3% | · | 3.3% | 3.0% | 2.5% | · | 1.9% | 3.3% | 0.14% | · | 3.8% | 3.9% | 3.4% | · | 7.7% | |
| EBITDA Margin | 4.7% | 4.4% | · | 4.7% | 4.5% | 4.0% | · | 4.0% | 4.0% | 5.2% | · | 4.6% | 4.6% | 5.9% | · | 4.7% | |
| ROA | 1.1% | 1.1% | · | 1.2% | 1.1% | 0.93% | · | 0.54% | 1.1% | -0.14% | · | 0.99% | 1.0% | 0.87% | · | 1.9% | |
| ROE | 4.0% | 4.0% | · | 4.7% | 4.0% | 3.5% | · | 1.9% | 3.8% | -0.49% | · | 3.2% | 3.3% | 2.9% | · | 6.0% | |
| ROIC | 5.1% | 4.6% | · | 5.3% | 4.6% | 4.2% | · | 4.1% | 4.7% | -14.4% | · | 3.7% | 3.9% | 3.7% | · | 3.8% |
Płynność i wypłacalność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.9 | 0.8 | 0.8 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | |
| Quick Ratio | 0.7 | 0.7 | · | 0.7 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | |
| Debt / Equity | 0.0 | · | · | · | · | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | 0.0 |
Efektywność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Inventory Turnover | 9.6 | 9.8 | · | 10.4 | 9.6 | 9.9 | · | 10.0 | 9.2 | 9.4 | · | 8.0 | 8.1 | 8.2 | · | 9.0 | |
| Receivables Turnover | 2.3 | 2.6 | · | 2.3 | 2.4 | 2.8 | · | 2.7 | 2.8 | 3.0 | · | 2.7 | 2.7 | 2.8 | · | 2.7 |
Wycena (TTM) 5
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $277.09B | $270.92B | · | $266.12B | $256.90B | $246.97B | · | $230.52B | $215.41B | $201.41B | · | $189.43B | $185.86B | $181.28B | · | $179.05B | |
| Net Income TTM | $6.82B | $6.58B | · | $5.84B | $5.50B | $3.65B | · | $3.69B | $4.38B | $4.05B | · | $7.04B | $7.16B | $6.87B | · | $7.20B | |
| P/E | 10.9 | 11.2 | · | 14.3 | 17.7 | 27.5 | · | 29.2 | 23.4 | 28.1 | · | 12.5 | 12.2 | 11.7 | · | 12.4 | |
| Earnings Yield | 9.2% | 8.9% | · | 7.0% | 5.6% | 3.6% | · | 3.4% | 4.3% | 3.6% | · | 8.0% | 8.2% | 8.5% | · | 8.1% | |
| Payout Ratio | · | 25.2% | · | · | · | 29.2% | · | · | · | -189.2% | · | · | · | 28.2% | · | · |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $274.90B | $247.12B | $195.26B | $180.52B | $174.07B |
| Marża Operacyjna % | 3.4% | 3.8% | 4.4% | 4.7% | 4.6% |
| Zysk netto | $5.96B | $3.43B | $5.16B | $6.78B | $5.42B |
| Rozwodniony EPS | $22.18 | $12.12 | $17.39 | $21.41 | $15.75 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Wskaźnik bieżący | 0.8 | 0.8 | 0.8 | 0.7 | 0.8 |
| Wskaźnik Szybkości | 0.7 | 0.6 | 0.5 | 0.6 | 0.5 |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Sygnały transakcyjne Ostatnie sygnały kupna/sprzedaży z ceną wejścia i wskaźnikiem ryzyka/zysku
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 1 880 emitentów · $43.5B łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 160 (-26 vs poprzedni kw.) | 90 (-25 vs poprzedni kw.) | 668 (+23 vs poprzedni kw.) | 583 (+4 vs poprzedni kw.) | +3.0M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $4 762 729 281 | 17 276 296 | 10,94% | Akcje |
| STATE STREET CORP | $3 496 245 161 | 12 682 259 | 8,03% | Akcje |
| Dodge & Cox | $3 356 093 871 | 12 173 875 | 7,71% | Akcje |
| Sanders Capital, LLC | $2 796 668 015 | 10 144 617 | 6,43% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 717 104 307 | 6 228 614 | 3,94% | Akcje |
| GQG Partners LLC | $1 628 918 123 | 5 908 707 | 3,74% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $1 480 812 562 | 5 399 567 | 3,40% | Akcje |
| FMR LLC | $1 045 833 560 | 3 793 651 | 2,40% | Akcje |
| NORGES BANK | $982 164 860 | 3 562 699 | 2,26% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $785 495 575 | 2 849 302 | 1,80% | Akcje |
| Grantham, Mayo, Van Otterloo & Co. LLC | $710 448 797 | 2 577 075 | 1,63% | Akcje |
| AMERIPRISE FINANCIAL INC | $683 415 995 | 2 478 794 | 1,57% | Akcje |
| Davis Selected Advisers | $621 243 564 | 2 253 424 | 1,43% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $600 639 178 | 2 178 755 | 1,38% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $599 490 928 | 2 174 590 | 1,38% | Akcje |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $558 018 223 | 2 024 152 | 1,28% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $499 838 165 | 1 813 110 | 1,15% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $409 373 497 | 1 484 959 | 0,94% | Akcje |
| Capital World Investors | $365 436 721 | 1 325 583 | 0,84% | Akcje |
| Capital Research Global Investors | $340 312 625 | 1 234 448 | 0,78% | Akcje |
| VICTORY CAPITAL MANAGEMENT INC | $297 765 000 | 1 080 111 | 0,68% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $295 639 232 | 1 072 400 | 0,68% | Opcja kupna |
| BloombergSen Inc. | $250 400 144 | 908 300 | 0,58% | Opcja kupna |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $241 311 801 | 875 333 | 0,55% | Akcje |
| BlackRock, Inc. | $229 573 898 | 832 755 | 0,53% | Akcje |
| RAYMOND JAMES FINANCIAL INC | $223 834 542 | 811 936 | 0,51% | Akcje |
| National Pension Service | $218 948 088 | 794 211 | 0,50% | Akcje |
| NORDEA INVESTMENT MANAGEMENT AB | $217 176 543 | 782 731 | 0,50% | Akcje |
| Sumitomo Mitsui Trust Group, Inc. | $210 159 410 | 762 331 | 0,48% | Akcje |
| Swiss National Bank | $205 012 464 | 743 661 | 0,47% | Akcje |
| LYRICAL ASSET MANAGEMENT LP | $204 993 443 | 743 592 | 0,47% | Akcje |
| Caisse de depot et placement du Quebec | $195 590 549 | 709 484 | 0,45% | Akcje |
| Swedbank AB | $189 698 992 | 688 113 | 0,44% | Akcje |
| NEUBERGER BERMAN GROUP LLC | $187 717 903 | 679 907 | 0,43% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $186 022 799 | 674 778 | 0,43% | Akcje |
| Legal & General Group Plc | $182 534 897 | 662 126 | 0,42% | Akcje |
| Mitsubishi UFJ Asset Management Co., Ltd. | $177 364 388 | 643 370 | 0,41% | Akcje |
| Vanguard Global Advisers, LLC | $173 779 299 | 630 366 | 0,40% | Akcje |
| Focused Investors LLC | $172 548 112 | 625 900 | 0,40% | Akcje |
| GOLDMAN SACHS GROUP INC | $166 646 906 | 604 494 | 0,38% | Akcje |
| VANGUARD ASSET MANAGEMENT, Ltd | $163 250 253 | 592 173 | 0,38% | Akcje |
| PZENA INVESTMENT MANAGEMENT LLC | $154 942 084 | 562 036 | 0,36% | Akcje |
| RHUMBLINE ADVISERS | $150 435 689 | 545 690 | 0,35% | Akcje |
| CANADA PENSION PLAN INVESTMENT BOARD | $148 808 756 | 539 788 | 0,34% | Akcje |
| PRUDENTIAL FINANCIAL INC | $141 115 078 | 511 880 | 0,32% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $140 128 144 | 508 300 | 0,32% | Opcja sprzedaży |
| California Public Employees Retirement System | $138 113 475 | 500 992 | 0,32% | Akcje |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $137 040 252 | 497 099 | 0,31% | Akcje |
| Walleye Trading LLC | $136 103 216 | 493 700 | 0,31% | Opcja kupna |
| ENVESTNET ASSET MANAGEMENT INC | $131 134 728 | 475 677 | 0,30% | Akcje |
| JANE STREET GROUP, LLC | $131 058 272 | 475 400 | 0,30% | Opcja sprzedaży |
| MILLENNIUM MANAGEMENT LLC | $125 612 214 | 455 645 | 0,29% | Akcje |
| Squarepoint Ops LLC | $124 438 920 | 451 389 | 0,29% | Akcje |
| BANK OF AMERICA CORP /DE/ | $118 315 239 | 429 176 | 0,27% | Akcje |
| LAKEWOOD CAPITAL MANAGEMENT, LP | $117 937 834 | 427 807 | 0,27% | Akcje |
| GLENVIEW CAPITAL MANAGEMENT, LLC | $113 641 637 | 412 223 | 0,26% | Akcje |
| MENORA MIVTACHIM HOLDINGS LTD. | $108 480 080 | 393 500 | 0,25% | Akcje |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $108 208 205 | 405 654 | 0,25% | Akcje |
| Man Group plc | $106 485 811 | 386 266 | 0,24% | Akcje |
| JANE STREET GROUP, LLC | $102 359 984 | 371 300 | 0,24% | Opcja kupna |
| PARNASSUS INVESTMENTS, LLC | $99 345 699 | 360 366 | 0,23% | Akcje |
| HSBC HOLDINGS PLC | $98 445 052 | 357 099 | 0,23% | Akcje |
| JONES FINANCIAL COMPANIES LLLP | $97 924 160 | 346 279 | 0,22% | Akcje |
| HighTower Advisors, LLC | $97 700 540 | 354 398 | 0,22% | Akcje |
| Qube Research & Technologies Ltd | $95 895 839 | 347 852 | 0,22% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $95 247 164 | 345 499 | 0,22% | Akcje |
| COOPERMAN LEON G | $89 596 000 | 325 000 | 0,21% | Akcje |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $88 633 118 | 321 070 | 0,20% | Akcje |
| UBS Group AG | $85 150 936 | 308 876 | 0,20% | Akcje |
| PRINCIPAL FINANCIAL GROUP INC | $84 423 968 | 306 239 | 0,19% | Akcje |
| Connor, Clark & Lunn Investment Management Ltd. | $83 067 071 | 301 317 | 0,19% | Akcje |
| Brandywine Global Investment Management, LLC | $83 043 221 | 301 723 | 0,19% | Akcje |
| BARCLAYS PLC | $81 058 191 | 294 030 | 0,19% | Akcje |
| NEW YORK STATE COMMON RETIREMENT FUND | $81 028 968 | 293 924 | 0,19% | Akcje |
| CITADEL ADVISORS LLC | $80 415 856 | 291 700 | 0,18% | Opcja kupna |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $77 231 334 | 284 500 | 0,18% | Akcje |
| D. E. Shaw & Co., Inc. | $77 230 098 | 280 144 | 0,18% | Akcje |
| FRANKLIN RESOURCES INC | $74 338 766 | 269 656 | 0,17% | Akcje |
| BANK OF NOVA SCOTIA | $73 763 722 | 267 570 | 0,17% | Akcje |
| CAPTRUST FINANCIAL ADVISORS | $73 593 768 | 266 954 | 0,17% | Akcje |
| Quantinno Capital Management LP | $72 042 853 | 261 327 | 0,17% | Akcje |
| LPL Financial LLC | $71 360 823 | 258 854 | 0,16% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $70 866 139 | 265 665 | 0,16% | Akcje |
| JANE STREET GROUP, LLC | $70 403 434 | 255 381 | 0,16% | Akcje |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $69 152 270 | 259 240 | 0,16% | Akcje |
| TD Asset Management Inc | $68 910 627 | 249 966 | 0,16% | Akcje |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $67 953 466 | 246 494 | 0,16% | Akcje |
| AVIVA PLC | $66 917 736 | 242 737 | 0,15% | Akcje |
| Susquehanna Portfolio Strategies, LLC | $65 143 735 | 236 302 | 0,15% | Akcje |
| Korea Investment CORP | $64 741 794 | 234 844 | 0,15% | Akcje |
| WOLVERINE TRADING, LLC | $64 525 530 | 225 110 | 0,15% | Akcje |
| Nuveen Asset Management, LLC | $64 039 904 | 231 911 | 0,15% | Akcje |
| PORTLAND INVESTMENT COUNSEL INC. | $62 303 680 | 226 000 | 0,14% | Akcje |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $60 990 065 | 221 235 | 0,14% | Akcje |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $60 432 000 | 219 209 | 0,14% | Akcje |
| BARCLAYS PLC | $60 098 240 | 218 000 | 0,14% | Opcja kupna |
| Ensign Peak Advisors, Inc | $59 737 375 | 216 691 | 0,14% | Akcje |
| CITADEL ADVISORS LLC | $58 912 816 | 213 700 | 0,14% | Opcja sprzedaży |
| Walleye Trading LLC | $58 863 745 | 213 522 | 0,14% | Akcje |
| FIRST TRUST ADVISORS LP | $57 187 000 | 207 440 | 0,13% | Akcje |
Insiderzy spółki 40 insiderów · 4 dyrektorzy generalni · 1 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Nicole S Jones | EVP, Chief Administrative Officer and Chief Human Resources Officer | 18 sierpnia 2026 S | 25 880 | 0 | 2 | $-6 118 100 |
| Bryan Holgerson | Title - President, Cigna Healthcare U.S. and EVP, Customer Health Outcomes | 6 sierpnia 2026 A | — | 0 | 0 | $0 |
| Jamie G Kates | Chief Accounting Officer | 12 czerwca 2026 M | 2 368 | 0 | 1 | $-268 450 |
| Durga Prasad Koka | EVP, Global CIO | 1 czerwca 2026 F | 6 552 | 0 | 0 | $0 |
| George Kurian | Dyrektor | 29 maja 2026 A | 3 778 | 0 | 0 | $0 |
| David Cordani | — | 3 listopada 2025 P | 157 935 | 1 | 0 | $999 932 |
| David J Brailer | — | 29 sierpnia 2025 F | 17 525 | 0 | 0 | $0 |
| Michael J Hennigan | — | 2 czerwca 2025 A | 568 | 0 | 0 | $0 |
| Neesha Hathi | — | 23 kwietnia 2025 A | 3 369 | 0 | 0 | $0 |
| Philip Ozuah | — | 23 kwietnia 2025 A | 1 801 | 0 | 0 | $0 |
| Elder Granger | — | 23 kwietnia 2025 A | 6 109 | 0 | 0 | $0 |
| Mark B. Mcclellan | — | 23 kwietnia 2025 A | 6 109 | 0 | 0 | $0 |
| Kimberly A. Ross | — | 23 kwietnia 2025 A | 4 512 | 0 | 0 | $0 |
| Kathleen M Mazzarella | — | 23 kwietnia 2025 A | 6 109 | 0 | 0 | $0 |
| Donna F Zarcone | — | 23 kwietnia 2025 A | 26 735 | 0 | 0 | $0 |
| Eric C Wiseman | — | 23 kwietnia 2025 A | 23 158 | 0 | 0 | $0 |
| Eric J Foss | — | 23 kwietnia 2025 A | 35 914 | 0 | 0 | $0 |
| Noelle K Eder | — | 7 marca 2025 S | 13 406 | 0 | 0 | $0 |
| Brian C Evanko | — | 28 lutego 2025 A | 51 182 | 0 | 0 | $0 |
| Eric P Palmer | — | 28 lutego 2025 A | 66 160 | 0 | 0 | $0 |
| William J Delaney III | — | 19 sierpnia 2024 M | 17 539 | 0 | 0 | $0 |
| Michael W Triplett | — | 12 sierpnia 2024 M | 32 833 | 0 | 0 | $0 |
| Mary T Hoeltzel | — | 14 maja 2024 M | 2 595 | 0 | 0 | $0 |
| Cynthia Ryan | — | 30 sierpnia 2023 M | 5 937 | 0 | 0 | $0 |
| Everett Neville | — | 20 lipca 2023 M | 5 987 | 0 | 0 | $0 |
| Paul A Sanford | — | 19 lipca 2023 S | 8 679 | 0 | 0 | $0 |
| Jason D Sadler | — | 24 lutego 2023 A | 47 015 | 0 | 0 | $0 |
| Charles Berg | — | 8 lutego 2023 G | — | 0 | 0 | $0 |
| John Partridge | — | 26 kwietnia 2022 A | 28 177 | 0 | 0 | $0 |
| MURABITO JOHN M | — | 1 marca 2022 F | 51 226 | 0 | 0 | $0 |
| HARRIS ISAIAH JR | — | 30 listopada 2021 A | 20 015 | 0 | 0 | $0 |
| Matthew G Manders | — | 19 listopada 2021 F | 43 488 | 0 | 0 | $0 |
| Timothy C Wentworth | — | 12 maja 2021 G | 29 783 | 0 | 0 | $0 |
| Kristen Lauria | — | 30 kwietnia 2021 F | 2 785 | 0 | 0 | $0 |
| Steven B Miller | — | 26 lutego 2021 F | 28 439 | 0 | 0 | $0 |
| William L Roper | — | 26 lutego 2021 A | 8 583 | 0 | 0 | $0 |
| Roman Martinez IV | — | 30 listopada 2020 A | 48 839 | 0 | 0 | $0 |
| Mark L Boxer | — | 28 lutego 2020 F | 49 191 | 0 | 0 | $0 |
| ZOLLARS WILLIAM D | — | 13 września 2019 S | 13 500 | 0 | 0 | $0 |
| Lisa R Bacus | — | 1 marca 2019 F | 24 024 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 242 fundusze ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| IHF · iShares Trust | 3,93% | 174 722 SH | 21 sierpnia 2026 | Dziennie |
| DUSA · Davis Fundamental ETF Trust | 3,26% | 130 244 NS | 30 kwietnia 2026 | N-PORT |
| MDPL · Northern Lights Fund Trust IV | 3,15% | 6 901 NS | 31 maja 2026 | N-PORT |
| MFSV · MFS Active Exchange Traded Funds Tr… | 2,77% | 47 358 NS | 31 maja 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 2,36% | 70 938 NS | 30 kwietnia 2026 | N-PORT |
| MVFD · Northern Lights Fund Trust IV | 2,35% | 9 177 NS | 31 maja 2026 | N-PORT |
| SMRI · EA Series Trust | 2,01% | 37 417 NS | 30 kwietnia 2026 | N-PORT |
| LYLD · Cambria ETF Trust | 1,96% | 406 NS | 30 kwietnia 2026 | N-PORT |
| QDIV · Global X Funds | 1,89% | 2 232 NS | 31 maja 2026 | N-PORT |
| WBIL · Absolute Shares Trust | 1,86% | 2 057 NS | 30 czerwca 2026 | N-PORT |
| BMVP · Invesco Exchange-Traded Fund Trust | 1,69% | 6 505 SH | 21 sierpnia 2026 | Dziennie |
| RUNN · Strategic Trust | 1,67% | 20 819 NS | 31 maja 2026 | N-PORT |
| QLTY · GMO ETF Trust | 1,60% | 260 100 NS | 31 maja 2026 | N-PORT |
| NUDV · Nushares ETF Trust | 1,59% | 2 485 NS | 30 kwietnia 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 1,55% | 97 920 SH | 21 sierpnia 2026 | Dziennie |
| GMOV · GMO ETF Trust | 1,53% | 5 024 NS | 31 maja 2026 | N-PORT |
| DWLD · Davis Fundamental ETF Trust | 1,53% | 29 890 NS | 30 kwietnia 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,34% | 40 080 SH | 21 sierpnia 2026 | Dziennie |
| FBCV · FIDELITY COVINGTON TRUST | 1,29% | 7 062 NS | 30 kwietnia 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 1,27% | 459 146 SH | 21 sierpnia 2026 | Dziennie |
| PWV · Invesco Exchange-Traded Fund Trust | 1,27% | 85 799 SH | 21 sierpnia 2026 | Dziennie |
| FHLC · FIDELITY COVINGTON TRUST | 1,25% | 123 144 NS | 30 kwietnia 2026 | N-PORT |
| FFLV · FIDELITY COVINGTON TRUST | 1,12% | 669 NS | 30 kwietnia 2026 | N-PORT |
| SPGP · Invesco Exchange-Traded Fund Trust | 1,11% | 92 344 SH | 21 sierpnia 2026 | Dziennie |
| IYH · iShares Trust | 1,11% | 155 756 SH | 21 sierpnia 2026 | Dziennie |
| CURE · Direxion Shares ETF Trust | 1,10% | 5 254 NS | 30 kwietnia 2026 | N-PORT |
| REVS · Columbia ETF Trust I | 1,07% | 10 450 NS | 30 kwietnia 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 1,07% | 792 582 SH | 19 sierpnia 2026 | Dziennie |
| RXL · ProShares Trust | 1,06% | 2 747 NS | 31 maja 2026 | N-PORT |
| SYLD · Cambria ETF Trust | 1,01% | 33 396 NS | 30 kwietnia 2026 | N-PORT |
| RILA · Spinnaker ETF Series | 1,01% | 1 451 NS | 30 kwietnia 2026 | N-PORT |
| BRCE · MFS Active Exchange Traded Funds Tr… | 0,98% | 1 172 NS | 31 maja 2026 | N-PORT |
| PALC · Pacer Funds Trust | 0,97% | 7 697 NS | 30 kwietnia 2026 | N-PORT |
| PY · Principal Exchange-Traded Funds | 0,97% | 7 728 NS | 30 czerwca 2026 | N-PORT |
| IMCV · iShares Trust | 0,96% | 41 362 SH | 21 sierpnia 2026 | Dziennie |
| FTA · First Trust Exchange-Traded AlphaDE… | 0,95% | 42 432 NS | 30 kwietnia 2026 | N-PORT |
| RFDA · ALPS ETF Trust | 0,95% | 2 980 NS | 31 maja 2026 | N-PORT |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0,89% | 30 937 177 | 21 sierpnia 2026 | Dziennie |
| IXJ · iShares Trust | 0,88% | 139 115 SH | 21 sierpnia 2026 | Dziennie |
| VLUE · iShares Trust | 0,87% | 310 167 SH | 21 sierpnia 2026 | Dziennie |
| EQIN · Columbia ETF Trust I | 0,83% | 7 926 NS | 30 kwietnia 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,80% | 24 655 SH | 19 sierpnia 2026 | Dziennie |
| NULV · Nushares ETF Trust | 0,79% | 56 180 NS | 30 kwietnia 2026 | N-PORT |
| ACLC · AMERICAN CENTURY ETF TRUST | 0,77% | 8 508 NS | 31 maja 2026 | N-PORT |
| FCFY · First Trust Exchange-Traded Fund | 0,76% | 37 NS | 30 czerwca 2026 | N-PORT |
| ASLV · ALLSPRING EXCHANGE-TRADED FUNDS TRU… | 0,72% | 5 530 NS | 30 kwietnia 2026 | N-PORT |
| UPSD · ETF Series Solutions | 0,67% | 2 343 NS | 30 kwietnia 2026 | N-PORT |
| SPVU · Invesco Exchange-Traded Fund Trust … | 0,65% | 3 174 NS | 31 maja 2026 | N-PORT |
| QARP · DBX ETF Trust | 0,64% | 1 727 NS | 29 maja 2026 | N-PORT |
| CVY · Invesco Exchange-Traded Fund Trust | 0,62% | 2 824 SH | 21 sierpnia 2026 | Dziennie |